Clover Health Investments (CLOV) Stock: Buy, Sell, or Hold?
CLOV - Clover Health Investments, Corp
$4.73
-0.05 (-1.05%)
âŧ
5d:
+1.07%
30d:
+3.5%
90d:
+9.49%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 04, 2026
12d
Get Alerted When CLOV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: CLOV is fairly priced but lacks strong directional signals. At -3.2% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: CLOV is fairly priced but lacks strong directional signals. At -3.2% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: CLOV is currently trading at $4.73, which is considered slightly high relative to its 30-day fair value range of $4.40 to $4.78. The stock's valuation (Forward PE: 31.9) is in line with its historical norms (35.1). Remarkably, the market is currently pricing in an annual earnings decline of 3.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CLOV is in a downtrend. Immediate support is located at $4.30, while resistance sits at $5.21.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.38 (+12.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CLOV is in a downtrend. Immediate support is located at $4.30, while resistance sits at $5.21.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.38 (+12.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$4.40 -
$4.78
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
62.9%
Protect Your Profits
Holding CLOV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Mixed technical signals (49/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($5.38)
- WARNING: Composite score 44/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.40 -
$4.78
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$4.30
Resistance Level
$5.21
Current Trend
Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
31.87
Wall Street Target
$5.38
(+12.4%)
Revenue Growth (YoY)
55.6%
Profit Margin
-0.7%
Valuation Discount vs History
-3.2% cheaper
PE vs Historical
31.9 vs 35.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.2%
(market-implied from PE analysis)
1-Year Target
$4.63
(-3%)
2-Year Target
$4.48
(-6%)
3-Year Target
$4.34
(-9%)
3-Yr Target (if PE normalizes)
(PE: 32â35)
$4.78
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 31.9, Growth: 7.1%)
$5.88
(+23%)
Base:
(SPY PE: 19.9, Growth: 7.1%)
$3.66
(-23%)
Bear:
(PE: 16.9, Growth: 7.1%)
$3.11
(-35%)
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 31.9 to 35.1
Stabilization Target:
$5.26
(+10.1%)
PE Expansion Potential:
+10.1%
Share & Embed Analysis
Last updated: October 22, 2026 4:52 PM ET
Data refreshes hourly during market hours. Next update: 5:52 PM
Data refreshes hourly during market hours. Next update: 5:52 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLOV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
27 analysts |
$115 | 39 SELL |
|
UNH
UnitedHealth Group IncorâĻ |
STRONG BUY
26 analysts |
$477 | 29 SELL |
|
HUM
Humana Inc |
BUY
26 analysts |
$465 | 37 SELL |
|
CI
Cigna Corp |
STRONG BUY
24 analysts |
$342 | 27 SELL |
|
ELV
Elevance Health Inc |
BUY
22 analysts |
$452 | 31 SELL |
Advanced CLOV Option Strategies
Professional options setups generated by AI based on today's CLOV price and gamma walls.
